Estimation of Radiobiologic Parameters and Equivalent Radiation Dose of Cytotoxic Chemotherapy in Malignant Glioma

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 2, 2007, Pages 441-448

  Jones, Bleddyn ^a   Sanghera, Paul ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Fractionation; Glioma; Radiobiology; Radiotherapy; Temozolomide

Indexed keywords

ANTIBIOTICS; CHEMOTHERAPY; COMPUTER SIMULATION; DOSIMETRY; FRACTIONATION; RADIOTHERAPY; TUMORS;

CELL SENSITIZERS; GLIOMA; RADIOBIOLOGY; TEMOZOLOMIDE;

PATIENT MONITORING;

CARBON; TEMOZOLOMIDE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DOSE ESCALATION; GLIOBLASTOMA; HUMAN; ION THERAPY; PRIORITY JOURNAL; RADIATION DOSE;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CELL DIVISION; DACARBAZINE; GLIOMA; HUMANS; MONTE CARLO METHOD; RADIOBIOLOGY; RELATIVE BIOLOGICAL EFFECTIVENESS; THERAPEUTIC EQUIVALENCY;

EID: 34247869639     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.12.025     Document Type: Article

References (30)

1. Dale R.G. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol 58 (1985) 515-528
2. Fowler J.F. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62 (1989) 679-694
3. Jones B., Dale R.G., Deehan C., et al. The role of biologically effective dose (BED) in clinical oncology. Clin Oncol 13 (2001) 71-81
4. Jones B., Cominos M., and Dale R.G. Application of biological effective dose (BED) to estimate the duration of symptomatic relief and repopulation dose equivalent in palliative radiotherapy and chemotherapy. Int J Radiat Oncol Biol Phys 55 (2003) 736-742
5. Jones B., Dale R.G., and Gaya A.M. Linear quadratic modeling of increased late normal-tissue effects in special clinical situations. Int J Radiat Oncol Biol Phys 64 (2006) 948-953
6. Geh J.I., Bond S.J., Bentzen S.M., et al. Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: Evidence of a radiation and chemotherapy dose response. Radiother Oncol 78 (2006) 236-244
7. Jones B., and Dale R.G. The potential for mathematical modelling in the assessment of the radiation dose equivalent of cytotoxic chemotherapy given concomitantly with radiotherapy. Br J Radiol 78 (2005) 939-944
8. Bleehen N.M., Stenning S.P., and Medical Research Council Brain Tumour Working Party. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. Br J Cancer 64 (1991) 769-774
9. Stupp R., Mason W.P., van den Bent M.J., et al., European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups and National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 (2005) 987-996
10. Burnet N.G., Jena R., Jefferies S.J., et al. Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment. Clin Oncol (R Coll Radiol) 18 (2006) 93-103
11. 2 distribution and bioreductive enzymes in human malignant brain tumors. Int J Radiat Oncol Biol Phys 29 (1994) 427-431
12. Kayama T., Yoshimoto T., Fujimoto T., et al. Intratumoral oxygen pressure in malignant brain tumor. J Neurosurg 74 (1991) 55-59
13. Collingridge D.R., Piepmeier J.M., Rockwell S., et al. Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. Radiother Oncol 53 (1999) 127-131
14. Tannock I.F., and Steel G.G. Tumor growth and cell kinetics in chronically hypoxic animals. J Natl Cancer Inst 45 (1970) 123-133
15. Jones B., and Campeljohn R.S. Stathmokinetic measurement of tumour cell proliferation in relation to vascular proximity. Cell Tissue Kinet 16 (1983) 351-355
16. Blankenberg F.G., Teplitz R.L., Ellis W., et al. The influence of volumetric tumor doubling time: DNA ploidy and histologic grade on the survival of patients with intracranial astrocytomas. Am J Neuroradiol 16 (1995) 1001-1012
17. Tsubio K., Yoshii Y., Nakagawa K., et al. Regrowth patterns of supratentorial gliomas: Estimation from computed tomographic scans. Neurosurgery 19 (1986) 946-951
18. Rew D.A., and Wilson G.D. Cell production rates in human tissues and tumours and their significance. Part II: Clinical data. Eur J Surg Oncol 26 (2000) 405-417
19. Steel G.G. The growth kinetics of tumours (1977), Clarendon, Oxford
20. Dale R.G., Hendry J.H., Jones B., et al. Practical methods for compensating for missed treatment days in radiotherapy, with particular reference to head & neck schedules. Clin Oncol 14 (2002) 382-393
21. Burnet N.G., Benson R.J., Williams M.V., et al. Improving cancer outcomes through radiotherapy: Lack of UK radiotherapy resources prejudices cancer outcomes. BMJ 320 (2000) 198-199
22. Do V., Gebski V., and Barton M.B. The effect of waiting for radiotherapy for grade III/IV gliomas. Radiother Oncol 57 (2000) 131-136
23. Pennington C., Kilbride L., Grant R., et al. A pilot study of brain tumour growth between radiotherapy planning and delivery. Clin Oncol 18 (2006) 104-108
24. The Royal College of Radiologists. Guidelines for the management of the unscheduled interruption or prolongation of a radical course of radiotherapy. Order reference BFCO(02)5 (2002), The Royal College of Radiologists, London
25. Fitzek M.M., Thornton A.F., Rabinov J.D., et al. Accelerated fractionated proton/photon irradiation to 90 Gy cobalt Gray equivalent for glioblastoma multiforme: Results of a phase II prospective trial. J Neurosurg 91 (1999) 251-260
26. Bleehan N.M. Studies on high grade cerebral gliomas. Int J Radiat Oncol Biol Phys 18 (1990) 811-813
27. Fulton D.S., Urtasun R.C., Shin K.H., et al. Misonidazole combined with hyperfractionation in the management of malignant glioma. Int J Radiat Oncol Biol Phys 10 (1984) 1709-1712
28. Jones B., and Dale R.G. Inclusion of molecular biotherapies with radical radiotherapy: Modelling of combined modality treatment schedules. Int J Radiat Oncol Biol Phys 45 (1999) 1025-1034
29. Dale R.G. Time-dependent tumor repopulation factors in the linear quadratic equations: Implications for therapeutic strategies. Radiother Oncol 15 (1989) 371-382
30. Dale R.G., and Jones B. The clinical radiobiology of brachytherapy. Br J Radiol 71 (1998) 465-483